Skip to main content

Evolus: Chiseling Away At The Aesthetic Market

Evolus is a facial beauty company that specializes in aesthetic neurotoxins. The market opportunity for Evolus is significant, with the neurotoxin market estimated at $3.5 billion and the dermal fillers market at $2.5 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.